Literature DB >> 12879167

Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population.

Veerapol Kukongviriyapan1, Auemduan Prawan, Benjamart Warasiha, Wichittra Tassaneyakul, Jareerat Aiemsa-ard.   

Abstract

OBJECTIVES: To analyze the common allele frequencies of the arylamine-N-acetyltransferase 1 (NAT1) and examine the relationship between genotype and phenotype in a Thai population.
METHODS: Peripheral blood samples from 233 Thai individuals were analyzed for genotype using polymerase chain reaction with restriction fragment-length polymorphism assays and for phenotype by determination of NAT1 enzyme kinetics in leukocytes using para-aminobenozic acid as a specific substrate.
RESULTS: Of 466 NAT1 alleles assayed, the frequency of the NAT1*4 allele (wild-type) was 0.504 (95%CI 0.458-0.551) and those of the NAT1*10, *3 and *11 alleles were 0.438 (0.392-0.484), 0.034 (0.02-0.055) and 0.024 (0.012-0.042), respectively. Neither NAT1*14A nor *14B alleles were found in this studied population. The activity of NAT1 enzyme from peripheral blood leukocytes determined in 47 subjects was found to vary widely. The intrinsic clearance and Vmax values of NAT1 enzymes with genotypes NAT1 *4/*4, *10/*10 and *4/ *10 were not significantly different.
CONCLUSION: The frequency distribution of the major NAT1 alleles in the Thai population has a similar pattern to some Asian populations; however, racial differences among Asian populations need further clarification.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879167     DOI: 10.1007/s00228-003-0630-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  32 in total

1.  Arylamine N-acetyltransferase activities in human breast cancer tissues.

Authors:  Y S Geylan; S Dizbay; T Güray
Journal:  Neoplasma       Date:  2001       Impact factor: 2.575

2.  Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).

Authors:  C Bruhn; J Brockmöller; I Cascorbi; I Roots; H H Borchert
Journal:  Biochem Pharmacol       Date:  1999-12-01       Impact factor: 5.858

3.  Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.

Authors:  A Sekine; S Saito; A Iida; Y Mitsunobu; S Higuchi; S Harigae; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

4.  Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1.

Authors:  A J Fretland; M A Doll; M A Leff; D W Hein
Journal:  Pharmacogenetics       Date:  2001-08

5.  Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe.

Authors:  N C Hughes; S A Janezic; K L McQueen; M A Jewett; T Castranio; D A Bell; D M Grant
Journal:  Pharmacogenetics       Date:  1998-02

6.  A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

Authors:  T P Reilly; L H Lash; M A Doll; D W Hein; P M Woster; C K Svensson
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

Review 7.  N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

8.  Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells.

Authors:  N J Butcher; K F Ilett; R F Minchin
Journal:  Mol Pharmacol       Date:  2000-03       Impact factor: 4.436

9.  Molecular analysis of the N-acetyltransferase 1 gene (NAT1*) using polymerase chain reaction-restriction fragment-single strand conformation polymorphism assay.

Authors:  J M Lo-Guidice; D Allorge; D Chevalier; H Debuysère; F Fazio; L J Lafitte; F Broly
Journal:  Pharmacogenetics       Date:  2000-06

10.  A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles.

Authors:  A C Deitz; M A Doll; D W Hein
Journal:  Anal Biochem       Date:  1997-11-15       Impact factor: 3.365

View more
  3 in total

1.  Inflammatory cytokines suppress arylamine N-acetyltransferase 1 in cholangiocarcinoma cells.

Authors:  Benjaporn Buranrat; Auemduan Prawan; Banchob Sripa; Veerapol Kukongviriyapan
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 2.  Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review.

Authors:  David W Hein; Giannoulis Fakis; Sotiria Boukouvala
Journal:  Pharmacogenet Genomics       Date:  2018-10       Impact factor: 2.089

3.  Genetic Polymorphisms of Pesticide-Metabolizing Enzymes and Transporters in Agricultural Workers and Thyroid Hormone Levels.

Authors:  Jintana Sirivarasai; Suwanee Chanprasertyothin; Pornpimol Kongtip; Susan Woskie
Journal:  Risk Manag Healthc Policy       Date:  2021-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.